Lessening the impact of cancer-causing hormones

February 9, 2012
Professor Peter Mackenzie

Increasing the production of proteins that help rid the body of toxins may play a crucial role in the fight against breast and prostate cancer, researchers from Flinders University believe.

Professor Peter Mackenzie (pictured), a Senior Principal Research Fellow in the School of Medicine, is leading a novel study that aims to boost the body’s supply of UGT enzymes – a family of proteins that eliminate fat soluble chemicals from the body by making them water soluble so they become less toxic and pass through the kidneys more readily.

Fat soluble chemicals include many therapeutic drugs, vitamins, environmental pollutants and the two steroid hormones oestrogen and testosterone.

While most fat soluble chemicals are not directly harmful, their levels need to be controlled as they can accumulate in the body to toxic levels.

As oestrogen and testosterone are known to stimulate the growth of breast and prostate cancers, their removal by UGT enzymes may help reduce cancer growth.

Professor Mackenzie said his research will analyse the properties of five specific enzymes responsible for metabolising oestrogen and testosterone to see how they can be maximised in cancer cells to lower hormone levels.

By increasing the amount of enzymes, Professor Mackenzie said it is hoped that levels in cancer cells can be reduced, thereby preventing or delaying the spread of disease.

“The initial stages of breast cancer are driven by oestrogen – once a cell changes to become a cancer, oestrogen contributes to its growth and it’s the same with , its growth is fuelled by abnormal androgen action,” Professor Mackenzie said.

“So if we can find a way to maximise the amount of enzymes made in these cells it might help reduce growth driven by oestrogen or testosterone because without this growth, hormone-dependent cancers such as breast and prostate cancer can’t survive,” he said.

“Unfortunately it will take some time to understand the underlying mechanisms, and then the next battle will be to find a drug that can increase the enzymes without being toxic or affecting the growth of the cell in a positive way.”

The three-year study will also investigate how therapeutic drugs can be used more effectively “so when they’ve carried out what they’re supposed to do, they leave the body and don’t accumulate to toxic levels”, Professor Mackenzie said.

Explore further: Reprogrammed oestrogen binding linked to more aggressive breast cancer

Related Stories

Reprogrammed oestrogen binding linked to more aggressive breast cancer

January 4, 2012
(Medical Xpress) -- Scientists based at Cancer Research UK’s Cambridge Research Institute have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients ...

Elevated hormone levels add up to increased breast cancer risk

October 21, 2011
Post-menopausal women with high levels of hormones such as estrogen or testosterone are known to have a higher risk of breast cancer. New research published in BioMed Central's open access journal Breast Cancer Research looked ...

Scientists find new drug target in breast cancer

May 22, 2011
Researchers have identified a new protein involved in the development of drug resistance in breast cancer which could be a target for new treatments, they report today in the journal Nature Medicine.

New hope for advanced post-menopausal breast cancer patients resistant to hormonal therapy

September 26, 2011
Results from a phase III clinical trial have shown that combining two existing cancer drugs to treat post-menopausal women with advanced breast cancer resistant to hormonal therapy significantly improves outcome. Researchers ...

Recommended for you

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.